Skip to content
Screener

Inovio Pharmaceuticals INO Q1 2025 earnings

Reported May 13, 2025 · After market close

Revenue$65.3KBeat by $55.3K
EPS-$0.51Beat by $0.23
Revenue estimate$10.0K
EPS estimate-$0.74

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$2.3M
EPS estimate-$0.20

Versus estimates

Revenue

Q1 2025$65.3KBeat by $55.3K

Diluted EPS

Q2 2026-$0.07Beat by $0.15Q1 2026-$0.28Beat by $0.02Q4 2025$0.31Beat by $0.68Q3 2025-$0.44Beat by $0.07Q2 2025-$0.61Beat by $0.02
Q1 2025-$0.51Beat by $0.23

FAQ

When did Inovio Pharmaceuticals report Q1 2025 earnings?
Inovio Pharmaceuticals (INO) reported Q1 2025 earnings on May 13, 2025 after market close.
What were Inovio Pharmaceuticals's Q1 2025 revenue and EPS?
Inovio Pharmaceuticals reported revenue of $65.3K and eps of $-0.51 for Q1 2025.
Did Inovio Pharmaceuticals beat estimates in Q1 2025?
Revenue beat the consensus estimate of $10.0K by $55.3K. EPS beat the consensus estimate of $-0.74 by $0.23.
How did Inovio Pharmaceuticals's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 61.1% from $-1.31.
Where can I find Inovio Pharmaceuticals's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001055726-25-000027) and the 10-Q periodic report (0001055726-25-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.